33 Result(s)

Article

BACNN: Multi-scale feature fusion-based bilinear attention convolutional neural network for wood NIR classification

Effective development and utilization of wood resources is critical. Wood modification research has become an integral dimension of wood science research, however, the similarities between modified wood and or...

Zihao Wan, Hong Yang, Jipan Xu, Hongbo Mu, Dawei Qi in Journal of Forestry Research (2023)

Article

Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer

Many patients with human epidermal growth factor receptor-2-positive metastatic breast cancer (HER2+ mBC) require subsequent lines of therapy (LOTs) after being treated with pertuzumab and trastuzumab-based re...

Sandhya Mehta, Jipan **e, Raluca Ionescu-Ittu, **aoyu Nie… in Oncology and Therapy (2023)

Article

Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR TKIs) are established first-line treatments among patients with metastatic non-small cell lung cancer harboring EGFR-sensitizing mutations. Upo...

Elizabeth Marrett, Winghan Jacqueline Kwong, Jipan **e… in Drugs - Real World Outcomes (2023)

Article

Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid Leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective

Using individual patient-level data from the phase 3 VIALE-A trial, this study assessed the cost-effectiveness of venetoclax in combination with azacitidine compared with azacitidine monotherapy for patients n...

Keith W. Pratz, **nglei Chai, Jipan **e, Lei Yin, **aoyu Nie… in PharmacoEconomics (2022)

Article

Treatment Changes, Healthcare Resource Utilization, and Costs Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Database Study

There is limited evidence on therapies for obstructive hypertrophic cardiomyopathy (HCM), and data regarding treatment patterns and cost are scarce. This study assessed treatment patterns and economic outcomes...

Anjali T. Owens, Megan B. Sutton, Wei Gao, Jennifer T. Fine… in Cardiology and Therapy (2022)

Article

Reasons for Initiating Canakinumab among Patients with Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease in the U.S. Real-World Settings

The aim of this study was to understand the reasons for canakinumab initiation among patients with Still’s disease, including systemic juvenile idiopathic arthritis (SJIA) and adult-onset Still’s disease (AOSD...

Peter Hur, Esther Yi, Raluca Ionescu-Ittu, Ameur M. Manceur… in Rheumatology and Therapy (2022)

Article

Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States

Although canakinumab has demonstrated efficacy in multiple trials in patients with periodic fever syndromes (PFS), the evidence on initiation of canakinumab among PFS patients in real world setting is not well...

Peter Hur, Kathleen G. Lomax, Raluca Ionescu-Ittu… in Pediatric Rheumatology (2021)

Article

Synergistic effects of bast fiber seedling film and nano-silicon fertilizer to increase the lodging resistance and yield of rice

The use of bast fiber film can improve rice seedling quality, and nano-silicon fertilizer can increase rice yields. This study aimed to compare the effects of using bast fiber film, nano-silicon fertilizer, an...

Diankai Gong, Xue Zhang, JiPan Yao, Gui** Dai, Guangxing Yu… in Scientific Reports (2021)

Article

Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong

Lower-dose ceritinib (450 mg) once-daily with food was approved in 2018 in Hong Kong (HK) for first-line treatment of patients with anaplastic lymphoma kinase-positive (ALK +) advanced non-small cell lung canc...

Herbert H. Loong, Carlos K. H. Wong… in Cost Effectiveness and Resource Allocation (2020)

Article

Transcriptome-based selection and validation of optimal house-kee** genes for skin research in goats (Capra hircus)

In quantitative real-time polymerase chain reaction (qRT-PCR) experiments, accurate and reliable target gene expression results are dependent on optimal amplification of house-kee** genes (HKGs). RNA-seq tec...

Jipan Zhang, Chengchen Deng, Jialu Li, Yongju Zhao in BMC Genomics (2020)

Article

Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147–2160. doi:10.1007/s12325-019-00991-w

**lin Song, Wei Gao, Jipan **e, Simran Tiwana in Advances in Therapy (2020)

Article

Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

In the absence of head-to-head trials, this analysis aimed to provide a fair indirect comparison of the efficacy between blinatumomab and inotuzumab ozogamicin (InO), two treatments for adult patients with rel...

**lin Song, Qiufei Ma, Wei Gao, Ze Cong, Jipan **e… in Advances in Therapy (2019)

Article

Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review

To characterize US patients with ankylosing spondylitis (AS) who were treated with secukinumab and to assess rheumatologist-reported reasons for prescribing treatment in clinical practice.

Reeti Joshi, Dominick Latremouille-Viau, Mark K. Meiselbach… in Drugs - Real World Outcomes (2019)

Article

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

Secukinumab is a fully human anti-interleukin 17A monoclonal antibody approved for the treatment of psoriatic arthritis (PsA) in the United States. Few studies have investigated prescribing patterns among rheu...

Prashanth Sunkureddi, Dominick Latremouille-Viau… in Rheumatology and Therapy (2019)